Probiotic Traits and Anti-Biofilm Potential of Bacillus subtilis JS03 From Freshwater Sponge Ephydatia fluviatilis Against Clinical Pathogens
This study characterizes *Bacillus subtilis* JS03, isolated from the freshwater sponge *Ephydatia fluviatilis*, as a promising probiotic candidate due to its robust stress tolerance, non-pathogenic nature, and significant antimicrobial and anti-biofilm activity against various clinical pathogens.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Deep within the human body, a bustling community of microorganisms works tirelessly to maintain health, aiding digestion and training the immune system. For centuries, people have relied on beneficial bacteria, often called probiotics, to support this internal ecosystem, typically sourcing them from fermented foods or the human gut itself. However, nature offers a vast array of other environments where these helpful microbes might thrive, waiting to be discovered. One such overlooked habitat is the freshwater sponge, a simple, filter-feeding animal that lives in rivers and lakes. These sponges act as living filters, trapping water and the microscopic life within it, creating a unique chemical environment that encourages the growth of specialized bacteria. Scientists have long suspected that these hidden bacterial communities produce powerful compounds to protect their hosts, but the specific potential of bacteria living inside freshwater sponges remains largely unexplored territory.
Researchers set out to investigate this possibility by collecting samples of a freshwater sponge known as Ephydatia fluviatilis from a lake in India. Their goal was to isolate a specific bacterium from the sponge's tissue and determine if it possessed the traits necessary to function as a safe and effective probiotic for humans or animals. They focused on a strain they named Bacillus subtilis JS03. To confirm its identity, the team examined its physical shape under a microscope, tested how it reacted to various chemicals, and analyzed its genetic code. The results confirmed that the organism was indeed a member of the Bacillus family, a group of bacteria known for their ability to form tough, protective spores that allow them to survive harsh conditions where other bacteria might perish.
The first major hurdle for any probiotic is surviving the journey through the human digestive system. The stomach is a highly acidic environment, and the small intestine contains bile salts that can break down cell walls. The researchers tested whether Bacillus subtilis JS03 could withstand these assaults. They placed the bacteria in solutions mimicking stomach acid and found that while it struggled in extreme acidity, it survived quite well in moderately acidic conditions, with about 80 percent of the bacteria remaining alive after twenty-four hours at a pH level similar to that of the stomach after a meal. When exposed to bile salts, the strain showed remarkable resilience, with nearly 97 percent of the population surviving a high concentration of bile for three hours. This suggests the bacterium could successfully navigate the digestive tract to reach the intestines, where it might exert its beneficial effects.
Beyond survival, a good probiotic must be able to stick to the intestinal lining to do its work. The team measured how well the bacteria clung to surfaces and to each other. They found that the strain was highly hydrophobic, meaning it naturally repelled water and preferred to stick to oily surfaces, a trait that helps bacteria attach to the gut wall. In tests measuring how quickly the bacteria grouped together, nearly 90 percent of the population aggregated within four hours. This strong tendency to stick together and to surfaces indicates a high potential for colonizing the gut and establishing a stable presence, rather than simply passing through and being excreted.
Safety is the most critical requirement for any organism intended for human or animal consumption. The researchers rigorously checked for signs of danger, such as the ability to destroy red blood cells or produce toxins. The strain showed no signs of hemolysis, meaning it did not break down blood cells, and it lacked the production of lecithinase, an enzyme often associated with pathogenic bacteria. Furthermore, the team tested the bacterium against a range of common antibiotics to ensure it would not contribute to the growing problem of drug resistance. The results showed that while the strain was resistant to some older antibiotics like penicillin and tetracycline, it remained sensitive to several modern, critical drugs, including ciprofloxacin and meropenem. This pattern suggests that the strain does not carry dangerous, transferable resistance genes that could be passed to harmful bacteria.
Perhaps the most promising finding was the bacterium's ability to fight off harmful pathogens. The researchers tested the strain against several disease-causing bacteria, including Staphylococcus aureus and Enterococcus faecalis. The Bacillus subtilis JS03 produced substances that effectively inhibited the growth of these pathogens, creating clear zones where the harmful bacteria could not grow. It was particularly effective against Staphylococcus aureus, a common cause of infections. Additionally, the strain demonstrated an ability to degrade existing biofilms, which are slimy, protective layers that harmful bacteria build to shield themselves from treatment. By breaking down these defenses and preventing new ones from forming, the probiotic candidate showed a dual capability: it could both protect the host from infection and help clear existing infections.
The study concludes that this bacterium, isolated from an unexplored freshwater sponge, possesses a robust combination of traits that make it a strong candidate for a new probiotic. It can survive the harsh conditions of the gut, stick effectively to the intestinal wall, fight off dangerous pathogens, and do so without exhibiting signs of toxicity or spreading antibiotic resistance. While the findings are based on laboratory tests and further studies in living organisms are needed to confirm its full potential, the research highlights the freshwater sponge as a valuable source for discovering new, beneficial microbes. This discovery opens a new door in the search for natural solutions to support health, suggesting that the next generation of probiotics may come not from the yogurt on a shelf, but from the quiet, filtering sponges of our freshwater lakes.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.